NCT07176962
Recruiting
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Enrollment
1,800 pts
Location
China
Sponsor
Yingbin Liu, MD, PhD, FACS
NCT07136077 Phase 2
Recruiting
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Enrollment
20 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06792786
Recruiting
A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring
Enrollment
30 pts
Location
China
Sponsor
The Central Hospital of Lishui...